|
|
The application of PDCA method in liver-protective agents management |
SONG Dongsheng |
Department of Pharmacy, the First People's Hospital of Guangyuan City, Sichuan Province, Guangyuan 628000, China |
|
|
Abstract Objective To discuss the effect of PDCA method application in liver-protective agents management. Methods The application of liver-protective agents in the First People's Hospital of Guangyuan City from July 2014 to July 2016 were analyzed, of which, 100 cases of patients treated with liver-protective agents given no PDCA management method from July 2014 to July 2015 were selected as the control group, 100 cases of patients treated with liver-protective agents given PDCA management method from August 2015 to July 2016 were selected as the observation group. The scores of medicine management, adverse drug reaction rate, life quality scores, error rate of batch number management, error rate of drug dispensing, satisfaction of the two group were compared. Results The scores of storage environment, sorting placement, preservation method, date processing of liver-protective agents in the observation group were significantly higher than those in the control group (P < 0.05). The incidence of anaphylactic reaction, cardiovascular system injury, gastrointestinal tract injury, renal function injury, nervous system injury of the observation group were significantly lower than those of the control group (P < 0.05). Before the treatment of liver-protective agents, the scores of physical function, charactar status, social function, mental health of the two groups had no statistically significant differences (P > 0.05). After treatment, the scores of physical function, charactar status, social function, mental health of the two groups were all higher than those of before treatment, of which the observation group were significantly higher than those of the control group (P < 0.05). The error rates of batch number management and drug dispensing of the observation group were significantly lower than those of the control group (P < 0.05), while the satisfaction rate was higher than that of the control group (P < 0.05). Conclusion The application of PDCA method in liver-protective agents management can improve the management quality of drugs, decrease adverse drug reaction rate, increase life quality and satisfaction of patients. It is worthy of clinical application.
|
|
|
|
|
[1] 王爽,王钦,徐新.PDCA 管理法用于门诊药房高危药品管理的效果分析[J].中国药业,2016,25(23):77-79.
[2] Wang LR,Wang Y,Lou Y,et al. The role of quality control circles in sustained improvement of medical quality [J]. Springer Plus,2013,2(1):141.
[3] 张红梅,肖丽,朱淑华,等.PDCA管理法在降低我院住院药房退药率中的应用[J].实用药物与临床,2015,18(8):1003-1007.
[4] 隋继英,窦明金,陈金娜,等.PDCA 循环法用于住院药房药品调剂风险管理的实践[J].中国药事,2016,30(3):246-251.
[5] 陈柳欢,钟俊珊,陈施.PDCA 循环法提高药房管理质量分析[J].海峡药学,2016,28(7):293-294.
[6] 温明玲,张兰旭.应用PDCA循环管理降低中药房处方调配差错率[J].西部中医药,2013,26(12):42-44.
[7] 谭晓娜,徐晴姣,郭其.高危药品分级警示标识用于医院药品管理实践与体会[J].中国药业,2015,24(6):44-45.
[8] 郑咏池,唐仕炜.药品货位号管理模式在医院药房中的应用[J].华西医学 2014,29(6):1146-1148.
[9] 陆晓彤,王斌,胡松浩,等.基于PDCA循环管理体系在促进医院合理用药中的应用[J].儿科药学杂志,2014,20(7):48-50.
[10] 孟凡成,宋和娣.PDCA循环在妇保院药品不良反应上报中的应用分析[J].淮海医药,2016,34(2):162-163.
[11] 邵庆平.PDCA 循环管理方法在住院药房调剂差错分析中的运用[J].中国药事,2015,29(9):979-983.
[12] 沈楠,潘冬梅,卢丽珠,等.PDCA循环在改善门诊药房退药制度中的应用[J].中医药管理杂志,2016,24(5):72-73.
[13] Svedlund J,Sullivan M,Liedman B,et al. Quality of life after gastrectomy for gastric carcinoma controlled study of reconstructive procedures [J].World J Surg,1997,21(4):422-433.
[14] Zieren HU,Zipper K,Zieren J,et al. Quality of life after surgical treatment of gastric carcinoma [J]. Eur J Surg,1998,164(2):119-125.
[15] 沈烽,张健.我院门急诊处方退药管理方案的建立与实施[J].中国药房,2015,26(7):952-954.
[16] 黄师婧,郗恒,何琴.运用PDCA循环原理持续改进药品不良反应监测与成效[J].药品评价,2016,13(6):50-54.
[17] 王丹玲,赵丽萍,高旭.PDCA护理对恶性脑胶质瘤术后放疗联合替莫唑胺同期化疗所致不良反应患者生活质量的影响[J].中国医药导报,2014,11(24):130-132.
[18] 姜志勇,顾晓琼,陈卓瑶,等.我院应用PDCA循环法提高血浆输注合理率的实践[J].中华医院管理杂志,2014, 30(1):47-483.
[19] 张建堂,李国秀,王志太,等.药剂科管理中PDCA循环的应用及实践做法分析[J].中国医药科学,2016,6(6):90-93.
[20] 黄艳,王波,杨洪波.PDCA循环管理法在我院抗菌药物管理中的应用效果分析[J].中国药房,2014,25(21):2014-2016.
[21] 刘雪梅,吕艳春,霍嘉慧,等.临床药师在抗菌药物合理使用中的作用及效果分析[J].中国医药科学,2015,5(14):97-99.
[22] 杨楠,刘峰,张玉方.临床药师开展药品不良反应监管工作模式探讨[J].中国药房,2015,26(8):1079-1081.
[23] 吴君,刘丽萍,胡伟,等.应用PDCA循环提高医疗机构药品不良反应报告和监测管理质量[J].安徽医药,2013, 17(10):1808-1809.
[24] 王凤霞,沈钦华,樊国斌,等.我院190例药品不良反应报告分析[J].中国药房,2015,26(5):641-642. |
|
|
|